Clinical Trial Update: A Study for Identification of Predictive Immune Biomarker for Atezolizumab Therapy in NSCLC Patients

View source ↗

Summary

Completed clinical trial investigating predictive immune biomarkers for atezolizumab therapy in patients with non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Yonsei University | Conditions: Non Small Cell Lung Cancer | Status: COMPLETED